Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$14.3M
2 rounds on record
Latest round
$8M
Venture round · Sep 2018 · 8 yr ago
Team
69
US Form 5500 (plan participants) · Dec 2025 · +25% in a year
Revenue
$25M
2017 · SEC Form D 0001458565-18-000002
Backers
1
Summa Equity
The money's age
Long since its last round
96 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team of 69 was 55 · US Form 5500 (plan participants)
Sep 27, 2018
Raised a round Venture round $8M · SEC Form D
May 11, 2016
Raised a round Venture round $6.3M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2018 | $8M | — | SEC Form D |
| Venture round | May 2016 | $6.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Axion BioSystems, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Thomas O'brienExecutive Officer, DirectorSEC Form D
James RossExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
People

Thomas O'brien
Executive Officer, Director

James Ross
Executive Officer, Director

Glenn Epstein
Director

David Gibson
Director

Jay Teich
Director

Michelle Jarrard
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Atlanta
United States
HQ
Financials
Est. Annual Revenue
$15M
2017
Total raised
$14.3M
Latest round
Venture - Series Unknown
Funding rounds
2
Revenue
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2015 | $15M | $5M | $25M |
| 2017 | $15M | $5M | $25M |

Summa Equity